Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study
Summary Background We have shown that immunity to infection with Plasmodium falciparum can be induced experimentally in malaria-naive volunteers through immunisation by bites of infected mosquitoes while simultaneously preventing disease with chloroquine prophylaxis. This immunity was associated wit...
Gespeichert in:
Veröffentlicht in: | The Lancet (British edition) 2011-05, Vol.377 (9779), p.1770-1776 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1776 |
---|---|
container_issue | 9779 |
container_start_page | 1770 |
container_title | The Lancet (British edition) |
container_volume | 377 |
creator | Roestenberg, Meta, MD Teirlinck, Anne C, MSc McCall, Matthew BB, MD Teelen, Karina, BSc Makamdop, Krystelle Nganou, MSc Wiersma, Jorien, ADN Arens, Theo, BSc Beckers, Pieter, PhD van Gemert, GeertJan, BSc van de Vegte-Bolmer, Marga, BSc van der Ven, André JAM, Prof Luty, Adrian JF, PhD Hermsen, Cornelus C, PhD Sauerwein, Robert W, Prof |
description | Summary Background We have shown that immunity to infection with Plasmodium falciparum can be induced experimentally in malaria-naive volunteers through immunisation by bites of infected mosquitoes while simultaneously preventing disease with chloroquine prophylaxis. This immunity was associated with parasite-specific production of interferon γ and interleukin 2 by pluripotent effector memory cells in vitro. We aim to explore the persistence of protection and immune responses in the same volunteers. Methods In an open-label study at the Radboud University Nijmegen Medical Centre (Nijmegen, Netherlands), from November to December, 2009, we rechallenged previously immune volunteers (28 months after immunisation) with the bites of five mosquitoes infected with P falciparum . Newly recruited malaria-naive volunteers served as infection controls. Our primary outcome was the detection of blood-stage parasitaemia by microscopy. We assessed the kinetics of parasitaemia with real-time quantitative PCR (rtPCR) and recorded clinical signs and symptoms. In-vitro production of interferon γ and interleukin 2 by effector memory T cells was studied after stimulation with sporozoites and red blood cells infected with P falciparum . Differences in cellular immune responses between the study groups were assessed with the Mann-Whitney test. This study is registered with ClinicalTrials.gov , number NCT00757887. Findings Four of six immune volunteers were microscopically negative after rechallenge. rtPCR-based detection of blood-stage parasites in these individuals was negative throughout follow-up. Patent parasitaemia was delayed in the remaining two immunised volunteers. In-vitro assays showed the long-term persistence of parasite-specific pluripotent effector memory T-cell responses in protected volunteers. The four protected volunteers reported several mild to moderate adverse events, of which the most commonly reported symptom was headache (one to three episodes per volunteer). The two patients with delayed patency had adverse events similar to those in the control group. Interpretation Artificially induced immunity lasts longer than generally recorded after natural exposure; providing a new avenue of research into the mechanisms of malaria immunity. Funding Dioraphte Foundation. |
doi_str_mv | 10.1016/S0140-6736(11)60360-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_872138561</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673611603607</els_id><sourcerecordid>868375471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c598t-b529653f693cae80147c7557defb2d20592dc4bea6a9bcc31a60392a8510f02d3</originalsourceid><addsrcrecordid>eNqF0U1v1DAQBuAIgehS-AlAhFQBh4DtxHbCoQhVfEkrcSiVuFkTZ7JycexgJ8Dy63F2l0XqpSdfnnnlmTfLHlPyihIqXl8SWpFCyFK8oPSlIKUghbyTrWglq4JX8tvdbHUkJ9mDGK8JIZUg_H52wiinleD1KhvW3m2KCcOQj8FPqCfjXQ4bMC5O-QAWgoEc-iRy_D1iMAO6CWweRx_8H28mzI3zerawTL7JweV-RFdYaNHmvbfW_yrmMY_T3G0fZvd6sBEfHd7T7OrD-68Xn4r1l4-fL96tC82beipazhrBy140pQas0xpSS85lh33LOkZ4wzpdtQgCmlbrkkLav2FQc0p6wrryNHu-z007_ZgxTmowUaO14NDPUdWS0bLmgt4uRV3KdM5FPrshr_0cXFpjQUKSqqkS4nukg48xYK_GdDEIW0WJWnpTu97UUoqiVO16UzLNPTmEz-2A3XHqX1EJnB0ARA22D-C0if9dRWvOiEju6d714BVsQjJXl4xQTghlTVnxJN7uBaYCfhoMKmqDTmNnQqpfdd7c-tnzGwnaGmfSt77jFuPxLFRFpsg-ZMmgdJcgy79npNL9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>868670494</pqid></control><display><type>article</type><title>Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Roestenberg, Meta, MD ; Teirlinck, Anne C, MSc ; McCall, Matthew BB, MD ; Teelen, Karina, BSc ; Makamdop, Krystelle Nganou, MSc ; Wiersma, Jorien, ADN ; Arens, Theo, BSc ; Beckers, Pieter, PhD ; van Gemert, GeertJan, BSc ; van de Vegte-Bolmer, Marga, BSc ; van der Ven, André JAM, Prof ; Luty, Adrian JF, PhD ; Hermsen, Cornelus C, PhD ; Sauerwein, Robert W, Prof</creator><creatorcontrib>Roestenberg, Meta, MD ; Teirlinck, Anne C, MSc ; McCall, Matthew BB, MD ; Teelen, Karina, BSc ; Makamdop, Krystelle Nganou, MSc ; Wiersma, Jorien, ADN ; Arens, Theo, BSc ; Beckers, Pieter, PhD ; van Gemert, GeertJan, BSc ; van de Vegte-Bolmer, Marga, BSc ; van der Ven, André JAM, Prof ; Luty, Adrian JF, PhD ; Hermsen, Cornelus C, PhD ; Sauerwein, Robert W, Prof</creatorcontrib><description>Summary Background We have shown that immunity to infection with Plasmodium falciparum can be induced experimentally in malaria-naive volunteers through immunisation by bites of infected mosquitoes while simultaneously preventing disease with chloroquine prophylaxis. This immunity was associated with parasite-specific production of interferon γ and interleukin 2 by pluripotent effector memory cells in vitro. We aim to explore the persistence of protection and immune responses in the same volunteers. Methods In an open-label study at the Radboud University Nijmegen Medical Centre (Nijmegen, Netherlands), from November to December, 2009, we rechallenged previously immune volunteers (28 months after immunisation) with the bites of five mosquitoes infected with P falciparum . Newly recruited malaria-naive volunteers served as infection controls. Our primary outcome was the detection of blood-stage parasitaemia by microscopy. We assessed the kinetics of parasitaemia with real-time quantitative PCR (rtPCR) and recorded clinical signs and symptoms. In-vitro production of interferon γ and interleukin 2 by effector memory T cells was studied after stimulation with sporozoites and red blood cells infected with P falciparum . Differences in cellular immune responses between the study groups were assessed with the Mann-Whitney test. This study is registered with ClinicalTrials.gov , number NCT00757887. Findings Four of six immune volunteers were microscopically negative after rechallenge. rtPCR-based detection of blood-stage parasites in these individuals was negative throughout follow-up. Patent parasitaemia was delayed in the remaining two immunised volunteers. In-vitro assays showed the long-term persistence of parasite-specific pluripotent effector memory T-cell responses in protected volunteers. The four protected volunteers reported several mild to moderate adverse events, of which the most commonly reported symptom was headache (one to three episodes per volunteer). The two patients with delayed patency had adverse events similar to those in the control group. Interpretation Artificially induced immunity lasts longer than generally recorded after natural exposure; providing a new avenue of research into the mechanisms of malaria immunity. Funding Dioraphte Foundation.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(11)60360-7</identifier><identifier>PMID: 21514658</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Adaptive Immunity - immunology ; Adult ; Antibody Specificity - immunology ; Antimalarials - administration & dosage ; Antimalarials - adverse effects ; Aquatic insects ; Biological and medical sciences ; cell-mediated immunity ; chloroquine ; Chloroquine - administration & dosage ; Clinical medicine ; Culicidae ; disease control ; erythrocytes ; Female ; General aspects ; headache ; Hepatitis ; Human protozoal diseases ; Human subjects ; Humans ; immune response ; Immunization ; Immunization - adverse effects ; Immunization - methods ; Immunologic Memory - immunology ; Infectious diseases ; interferon-gamma ; Interferon-gamma - blood ; interleukin-2 ; Interleukin-2 - blood ; Internal Medicine ; Malaria ; Malaria, Falciparum - immunology ; Malaria, Falciparum - prevention & control ; Male ; Medical sciences ; microscopy ; Mosquitoes ; Netherlands ; parasitemia ; Parasites ; Parasitic diseases ; patients ; Plasmodium falciparum ; Plasmodium falciparum - immunology ; Prophylaxis ; Protozoal diseases ; quantitative polymerase chain reaction ; Reverse Transcriptase Polymerase Chain Reaction ; sporozoites ; Sporozoites - immunology ; T-lymphocytes ; T-Lymphocytes - immunology ; Vector-borne diseases ; volunteers ; Young Adult</subject><ispartof>The Lancet (British edition), 2011-05, Vol.377 (9779), p.1770-1776</ispartof><rights>Elsevier Ltd</rights><rights>2011 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited May 21-May 27, 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c598t-b529653f693cae80147c7557defb2d20592dc4bea6a9bcc31a60392a8510f02d3</citedby><cites>FETCH-LOGICAL-c598t-b529653f693cae80147c7557defb2d20592dc4bea6a9bcc31a60392a8510f02d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/868670494?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976,64364,64366,64368,72218</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24185206$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21514658$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roestenberg, Meta, MD</creatorcontrib><creatorcontrib>Teirlinck, Anne C, MSc</creatorcontrib><creatorcontrib>McCall, Matthew BB, MD</creatorcontrib><creatorcontrib>Teelen, Karina, BSc</creatorcontrib><creatorcontrib>Makamdop, Krystelle Nganou, MSc</creatorcontrib><creatorcontrib>Wiersma, Jorien, ADN</creatorcontrib><creatorcontrib>Arens, Theo, BSc</creatorcontrib><creatorcontrib>Beckers, Pieter, PhD</creatorcontrib><creatorcontrib>van Gemert, GeertJan, BSc</creatorcontrib><creatorcontrib>van de Vegte-Bolmer, Marga, BSc</creatorcontrib><creatorcontrib>van der Ven, André JAM, Prof</creatorcontrib><creatorcontrib>Luty, Adrian JF, PhD</creatorcontrib><creatorcontrib>Hermsen, Cornelus C, PhD</creatorcontrib><creatorcontrib>Sauerwein, Robert W, Prof</creatorcontrib><title>Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Summary Background We have shown that immunity to infection with Plasmodium falciparum can be induced experimentally in malaria-naive volunteers through immunisation by bites of infected mosquitoes while simultaneously preventing disease with chloroquine prophylaxis. This immunity was associated with parasite-specific production of interferon γ and interleukin 2 by pluripotent effector memory cells in vitro. We aim to explore the persistence of protection and immune responses in the same volunteers. Methods In an open-label study at the Radboud University Nijmegen Medical Centre (Nijmegen, Netherlands), from November to December, 2009, we rechallenged previously immune volunteers (28 months after immunisation) with the bites of five mosquitoes infected with P falciparum . Newly recruited malaria-naive volunteers served as infection controls. Our primary outcome was the detection of blood-stage parasitaemia by microscopy. We assessed the kinetics of parasitaemia with real-time quantitative PCR (rtPCR) and recorded clinical signs and symptoms. In-vitro production of interferon γ and interleukin 2 by effector memory T cells was studied after stimulation with sporozoites and red blood cells infected with P falciparum . Differences in cellular immune responses between the study groups were assessed with the Mann-Whitney test. This study is registered with ClinicalTrials.gov , number NCT00757887. Findings Four of six immune volunteers were microscopically negative after rechallenge. rtPCR-based detection of blood-stage parasites in these individuals was negative throughout follow-up. Patent parasitaemia was delayed in the remaining two immunised volunteers. In-vitro assays showed the long-term persistence of parasite-specific pluripotent effector memory T-cell responses in protected volunteers. The four protected volunteers reported several mild to moderate adverse events, of which the most commonly reported symptom was headache (one to three episodes per volunteer). The two patients with delayed patency had adverse events similar to those in the control group. Interpretation Artificially induced immunity lasts longer than generally recorded after natural exposure; providing a new avenue of research into the mechanisms of malaria immunity. Funding Dioraphte Foundation.</description><subject>Adaptive Immunity - immunology</subject><subject>Adult</subject><subject>Antibody Specificity - immunology</subject><subject>Antimalarials - administration & dosage</subject><subject>Antimalarials - adverse effects</subject><subject>Aquatic insects</subject><subject>Biological and medical sciences</subject><subject>cell-mediated immunity</subject><subject>chloroquine</subject><subject>Chloroquine - administration & dosage</subject><subject>Clinical medicine</subject><subject>Culicidae</subject><subject>disease control</subject><subject>erythrocytes</subject><subject>Female</subject><subject>General aspects</subject><subject>headache</subject><subject>Hepatitis</subject><subject>Human protozoal diseases</subject><subject>Human subjects</subject><subject>Humans</subject><subject>immune response</subject><subject>Immunization</subject><subject>Immunization - adverse effects</subject><subject>Immunization - methods</subject><subject>Immunologic Memory - immunology</subject><subject>Infectious diseases</subject><subject>interferon-gamma</subject><subject>Interferon-gamma - blood</subject><subject>interleukin-2</subject><subject>Interleukin-2 - blood</subject><subject>Internal Medicine</subject><subject>Malaria</subject><subject>Malaria, Falciparum - immunology</subject><subject>Malaria, Falciparum - prevention & control</subject><subject>Male</subject><subject>Medical sciences</subject><subject>microscopy</subject><subject>Mosquitoes</subject><subject>Netherlands</subject><subject>parasitemia</subject><subject>Parasites</subject><subject>Parasitic diseases</subject><subject>patients</subject><subject>Plasmodium falciparum</subject><subject>Plasmodium falciparum - immunology</subject><subject>Prophylaxis</subject><subject>Protozoal diseases</subject><subject>quantitative polymerase chain reaction</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>sporozoites</subject><subject>Sporozoites - immunology</subject><subject>T-lymphocytes</subject><subject>T-Lymphocytes - immunology</subject><subject>Vector-borne diseases</subject><subject>volunteers</subject><subject>Young Adult</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqF0U1v1DAQBuAIgehS-AlAhFQBh4DtxHbCoQhVfEkrcSiVuFkTZ7JycexgJ8Dy63F2l0XqpSdfnnnlmTfLHlPyihIqXl8SWpFCyFK8oPSlIKUghbyTrWglq4JX8tvdbHUkJ9mDGK8JIZUg_H52wiinleD1KhvW3m2KCcOQj8FPqCfjXQ4bMC5O-QAWgoEc-iRy_D1iMAO6CWweRx_8H28mzI3zerawTL7JweV-RFdYaNHmvbfW_yrmMY_T3G0fZvd6sBEfHd7T7OrD-68Xn4r1l4-fL96tC82beipazhrBy140pQas0xpSS85lh33LOkZ4wzpdtQgCmlbrkkLav2FQc0p6wrryNHu-z007_ZgxTmowUaO14NDPUdWS0bLmgt4uRV3KdM5FPrshr_0cXFpjQUKSqqkS4nukg48xYK_GdDEIW0WJWnpTu97UUoqiVO16UzLNPTmEz-2A3XHqX1EJnB0ARA22D-C0if9dRWvOiEju6d714BVsQjJXl4xQTghlTVnxJN7uBaYCfhoMKmqDTmNnQqpfdd7c-tnzGwnaGmfSt77jFuPxLFRFpsg-ZMmgdJcgy79npNL9</recordid><startdate>20110521</startdate><enddate>20110521</enddate><creator>Roestenberg, Meta, MD</creator><creator>Teirlinck, Anne C, MSc</creator><creator>McCall, Matthew BB, MD</creator><creator>Teelen, Karina, BSc</creator><creator>Makamdop, Krystelle Nganou, MSc</creator><creator>Wiersma, Jorien, ADN</creator><creator>Arens, Theo, BSc</creator><creator>Beckers, Pieter, PhD</creator><creator>van Gemert, GeertJan, BSc</creator><creator>van de Vegte-Bolmer, Marga, BSc</creator><creator>van der Ven, André JAM, Prof</creator><creator>Luty, Adrian JF, PhD</creator><creator>Hermsen, Cornelus C, PhD</creator><creator>Sauerwein, Robert W, Prof</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>F1W</scope><scope>H95</scope><scope>H97</scope><scope>L.G</scope></search><sort><creationdate>20110521</creationdate><title>Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study</title><author>Roestenberg, Meta, MD ; Teirlinck, Anne C, MSc ; McCall, Matthew BB, MD ; Teelen, Karina, BSc ; Makamdop, Krystelle Nganou, MSc ; Wiersma, Jorien, ADN ; Arens, Theo, BSc ; Beckers, Pieter, PhD ; van Gemert, GeertJan, BSc ; van de Vegte-Bolmer, Marga, BSc ; van der Ven, André JAM, Prof ; Luty, Adrian JF, PhD ; Hermsen, Cornelus C, PhD ; Sauerwein, Robert W, Prof</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c598t-b529653f693cae80147c7557defb2d20592dc4bea6a9bcc31a60392a8510f02d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adaptive Immunity - immunology</topic><topic>Adult</topic><topic>Antibody Specificity - immunology</topic><topic>Antimalarials - administration & dosage</topic><topic>Antimalarials - adverse effects</topic><topic>Aquatic insects</topic><topic>Biological and medical sciences</topic><topic>cell-mediated immunity</topic><topic>chloroquine</topic><topic>Chloroquine - administration & dosage</topic><topic>Clinical medicine</topic><topic>Culicidae</topic><topic>disease control</topic><topic>erythrocytes</topic><topic>Female</topic><topic>General aspects</topic><topic>headache</topic><topic>Hepatitis</topic><topic>Human protozoal diseases</topic><topic>Human subjects</topic><topic>Humans</topic><topic>immune response</topic><topic>Immunization</topic><topic>Immunization - adverse effects</topic><topic>Immunization - methods</topic><topic>Immunologic Memory - immunology</topic><topic>Infectious diseases</topic><topic>interferon-gamma</topic><topic>Interferon-gamma - blood</topic><topic>interleukin-2</topic><topic>Interleukin-2 - blood</topic><topic>Internal Medicine</topic><topic>Malaria</topic><topic>Malaria, Falciparum - immunology</topic><topic>Malaria, Falciparum - prevention & control</topic><topic>Male</topic><topic>Medical sciences</topic><topic>microscopy</topic><topic>Mosquitoes</topic><topic>Netherlands</topic><topic>parasitemia</topic><topic>Parasites</topic><topic>Parasitic diseases</topic><topic>patients</topic><topic>Plasmodium falciparum</topic><topic>Plasmodium falciparum - immunology</topic><topic>Prophylaxis</topic><topic>Protozoal diseases</topic><topic>quantitative polymerase chain reaction</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>sporozoites</topic><topic>Sporozoites - immunology</topic><topic>T-lymphocytes</topic><topic>T-Lymphocytes - immunology</topic><topic>Vector-borne diseases</topic><topic>volunteers</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roestenberg, Meta, MD</creatorcontrib><creatorcontrib>Teirlinck, Anne C, MSc</creatorcontrib><creatorcontrib>McCall, Matthew BB, MD</creatorcontrib><creatorcontrib>Teelen, Karina, BSc</creatorcontrib><creatorcontrib>Makamdop, Krystelle Nganou, MSc</creatorcontrib><creatorcontrib>Wiersma, Jorien, ADN</creatorcontrib><creatorcontrib>Arens, Theo, BSc</creatorcontrib><creatorcontrib>Beckers, Pieter, PhD</creatorcontrib><creatorcontrib>van Gemert, GeertJan, BSc</creatorcontrib><creatorcontrib>van de Vegte-Bolmer, Marga, BSc</creatorcontrib><creatorcontrib>van der Ven, André JAM, Prof</creatorcontrib><creatorcontrib>Luty, Adrian JF, PhD</creatorcontrib><creatorcontrib>Hermsen, Cornelus C, PhD</creatorcontrib><creatorcontrib>Sauerwein, Robert W, Prof</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roestenberg, Meta, MD</au><au>Teirlinck, Anne C, MSc</au><au>McCall, Matthew BB, MD</au><au>Teelen, Karina, BSc</au><au>Makamdop, Krystelle Nganou, MSc</au><au>Wiersma, Jorien, ADN</au><au>Arens, Theo, BSc</au><au>Beckers, Pieter, PhD</au><au>van Gemert, GeertJan, BSc</au><au>van de Vegte-Bolmer, Marga, BSc</au><au>van der Ven, André JAM, Prof</au><au>Luty, Adrian JF, PhD</au><au>Hermsen, Cornelus C, PhD</au><au>Sauerwein, Robert W, Prof</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2011-05-21</date><risdate>2011</risdate><volume>377</volume><issue>9779</issue><spage>1770</spage><epage>1776</epage><pages>1770-1776</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Summary Background We have shown that immunity to infection with Plasmodium falciparum can be induced experimentally in malaria-naive volunteers through immunisation by bites of infected mosquitoes while simultaneously preventing disease with chloroquine prophylaxis. This immunity was associated with parasite-specific production of interferon γ and interleukin 2 by pluripotent effector memory cells in vitro. We aim to explore the persistence of protection and immune responses in the same volunteers. Methods In an open-label study at the Radboud University Nijmegen Medical Centre (Nijmegen, Netherlands), from November to December, 2009, we rechallenged previously immune volunteers (28 months after immunisation) with the bites of five mosquitoes infected with P falciparum . Newly recruited malaria-naive volunteers served as infection controls. Our primary outcome was the detection of blood-stage parasitaemia by microscopy. We assessed the kinetics of parasitaemia with real-time quantitative PCR (rtPCR) and recorded clinical signs and symptoms. In-vitro production of interferon γ and interleukin 2 by effector memory T cells was studied after stimulation with sporozoites and red blood cells infected with P falciparum . Differences in cellular immune responses between the study groups were assessed with the Mann-Whitney test. This study is registered with ClinicalTrials.gov , number NCT00757887. Findings Four of six immune volunteers were microscopically negative after rechallenge. rtPCR-based detection of blood-stage parasites in these individuals was negative throughout follow-up. Patent parasitaemia was delayed in the remaining two immunised volunteers. In-vitro assays showed the long-term persistence of parasite-specific pluripotent effector memory T-cell responses in protected volunteers. The four protected volunteers reported several mild to moderate adverse events, of which the most commonly reported symptom was headache (one to three episodes per volunteer). The two patients with delayed patency had adverse events similar to those in the control group. Interpretation Artificially induced immunity lasts longer than generally recorded after natural exposure; providing a new avenue of research into the mechanisms of malaria immunity. Funding Dioraphte Foundation.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>21514658</pmid><doi>10.1016/S0140-6736(11)60360-7</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0140-6736 |
ispartof | The Lancet (British edition), 2011-05, Vol.377 (9779), p.1770-1776 |
issn | 0140-6736 1474-547X |
language | eng |
recordid | cdi_proquest_miscellaneous_872138561 |
source | MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland |
subjects | Adaptive Immunity - immunology Adult Antibody Specificity - immunology Antimalarials - administration & dosage Antimalarials - adverse effects Aquatic insects Biological and medical sciences cell-mediated immunity chloroquine Chloroquine - administration & dosage Clinical medicine Culicidae disease control erythrocytes Female General aspects headache Hepatitis Human protozoal diseases Human subjects Humans immune response Immunization Immunization - adverse effects Immunization - methods Immunologic Memory - immunology Infectious diseases interferon-gamma Interferon-gamma - blood interleukin-2 Interleukin-2 - blood Internal Medicine Malaria Malaria, Falciparum - immunology Malaria, Falciparum - prevention & control Male Medical sciences microscopy Mosquitoes Netherlands parasitemia Parasites Parasitic diseases patients Plasmodium falciparum Plasmodium falciparum - immunology Prophylaxis Protozoal diseases quantitative polymerase chain reaction Reverse Transcriptase Polymerase Chain Reaction sporozoites Sporozoites - immunology T-lymphocytes T-Lymphocytes - immunology Vector-borne diseases volunteers Young Adult |
title | Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T12%3A26%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20protection%20against%20malaria%20after%20experimental%20sporozoite%20inoculation:%20an%20open-label%20follow-up%20study&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Roestenberg,%20Meta,%20MD&rft.date=2011-05-21&rft.volume=377&rft.issue=9779&rft.spage=1770&rft.epage=1776&rft.pages=1770-1776&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(11)60360-7&rft_dat=%3Cproquest_cross%3E868375471%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=868670494&rft_id=info:pmid/21514658&rft_els_id=S0140673611603607&rfr_iscdi=true |